Robert Kowalczyk1, Krzysztof Nowosielski2, Ida Cedrych3, Marek Krzystanek4, Iwona Glogowska5, Joanna Streb6, Jakub Kucharz7, Zbigniew Lew-Starowicz8. 1. Department of Sexology, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland. 2. Department of Physiology, Opole Medical School, Poland. Electronic address: dr.krzysztof.nowosielski@gmail.com. 3. Department of Systemic and Generalized Malignancies, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Krakow Branch, Krakow, Poland. 4. Department of Psychiatry and Psychotherapy, Medical University of Silesia, Katowice, Poland. 5. Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. 6. Department of Oncology, Jagiellonian University Medical College, Krakow, Poland. 7. Department of Uro-Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. 8. Department of Sexual Rehabilitation, Academy of Physical Education, Warsaw, Poland.
Abstract
INTRODUCTION: Knowing the important factors influencing sexual function and body image might facilitate the recovery process of breast cancer survivors. Surgery type, relationship quality, and partner support might be modified to create a space for psychosexual intervention. PATIENTS AND METHODS: This retrospective questionnaire-based study was performed on 128 women aged 18 to 65 years who were free of disease at time of study entry and who underwent surgical treatment for breast cancer. Diagnostic and Statistical Manual of Mental Disorders criteria were used to assessed female sexual dysfunction (FSD). Changes in Sexual Functioning Questionnaire (CSFQ) were used to measure sexual function, whereas the Body Image After Breast Cancer Questionnaire (BIBCQ) was used to assess body image. The support of the partner was evaluated by the Provisions of Social Relation Scale (PSRS). RESULTS: The median age of the studied respondents was 52.5 ± 10.1 years. FSD was diagnosed in 27.3% women. Lower physical satisfaction in relationship (odds ratio [OR] = 2.3), undergoing mastectomy (OR = 4.1) higher level of anxiety (OR = 4.2), and shorter duration of relationship (OR = 1.1) as well as not receiving adjuvant chemotherapy (F = 3.54), higher level of emotional satisfaction in relationship (F = 20.32), longer time after completion of oncologic treatment (F = 8.76), undergoing breast-conserving therapy (compared to mastectomy) (F = 13.21), and lower level of anxiety (F = 31,25) were important factors for the prevalence of FSD and positive body image, respectively. CONCLUSION: Type of surgery, time after completion of treatment, level of anxiety, adjuvant chemotherapy, partner support, and satisfying quality of relationship are important factors for sexual function, sexual quality of life, and body image in female breast cancer survivors.
INTRODUCTION: Knowing the important factors influencing sexual function and body image might facilitate the recovery process of breast cancer survivors. Surgery type, relationship quality, and partner support might be modified to create a space for psychosexual intervention. PATIENTS AND METHODS: This retrospective questionnaire-based study was performed on 128 women aged 18 to 65 years who were free of disease at time of study entry and who underwent surgical treatment for breast cancer. Diagnostic and Statistical Manual of Mental Disorders criteria were used to assessed female sexual dysfunction (FSD). Changes in Sexual Functioning Questionnaire (CSFQ) were used to measure sexual function, whereas the Body Image After Breast Cancer Questionnaire (BIBCQ) was used to assess body image. The support of the partner was evaluated by the Provisions of Social Relation Scale (PSRS). RESULTS: The median age of the studied respondents was 52.5 ± 10.1 years. FSD was diagnosed in 27.3% women. Lower physical satisfaction in relationship (odds ratio [OR] = 2.3), undergoing mastectomy (OR = 4.1) higher level of anxiety (OR = 4.2), and shorter duration of relationship (OR = 1.1) as well as not receiving adjuvant chemotherapy (F = 3.54), higher level of emotional satisfaction in relationship (F = 20.32), longer time after completion of oncologic treatment (F = 8.76), undergoing breast-conserving therapy (compared to mastectomy) (F = 13.21), and lower level of anxiety (F = 31,25) were important factors for the prevalence of FSD and positive body image, respectively. CONCLUSION: Type of surgery, time after completion of treatment, level of anxiety, adjuvant chemotherapy, partner support, and satisfying quality of relationship are important factors for sexual function, sexual quality of life, and body image in female breast cancer survivors.
Authors: Leticia Aptecar; Frederic Fiteni; Marta Jarlier; Stephanie Delaine; Violaine Guillerme; William Jacot; Veronique D'Hondt Journal: Breast Cancer Res Treat Date: 2021-01-15 Impact factor: 4.872
Authors: Solveig K Smedsland; Kathrine F Vandraas; Synne K Bøhn; Alv A Dahl; Cecilie E Kiserud; Mette Brekke; Ragnhild S Falk; Kristin V Reinertsen Journal: Breast Cancer Res Treat Date: 2022-02-28 Impact factor: 4.872
Authors: Angelique Bobrie; Marta Jarlier; Aurore Moussion; William Jacot; Veronique D'Hondt Journal: Support Care Cancer Date: 2022-01-14 Impact factor: 3.359